POINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? Yes
COPD is a complex and heterogeneous disease characterized by chronic airway inflammation.1 The latter may alter airway antimicrobial defense systems and therefore favor the colonization of the bronchial mucosa by potentially pathogenic microorganisms (PPM).2 The most frequent PPMs that are capable of provoking clinical symptoms or that have impact in the COPD prognosis are listed here: Haemophilus influenza and parainfluenza, Streptococcus pneumoniae, Moraxella Catarrhalis, Pseudomonas aeruginosa, Staphylococcus aureus and some enterobacteriaceae. These PPMs, and more importantly, the presence of chronic bronchial infection (CBI), which is defined as the repeated isolation of PPMs from the airway overtime, could be a potential mechanism of disease progression and poor health outcomes in patients with COPD.3
Puedes leer el artículo completo aquí: https://journal.chestnet.org/article/S0012-3692(22)01251-X/fulltext
Noticias relacionadas

A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians
Explore the history of COPD and the evolution of disease concepts, treatment strategies, patient outcomes, pulmonary rehabilitation and clinical management.

High prevalence of obstructive sleep apnea in patients with Long-COVID
Sleep apnea is highly prevalent in Long-COVID patients. Sleep studies may help identify treatable causes of persistent symptoms and insomnia.

Climate change and respiratory health: implications for respiratory clinicians in primary and specialist care
How climate change affects asthma and COPD, the role of air pollution and inhalers, and why sustainable respiratory care matters for patients and clinicians.
Más artículos
COPD
- 759578·Alberto Papi et Al.-Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY
- 759785·Richard Beasley et Al – Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness
- 759788·Alvar Agustí, Rod Hughes, Eleni Rapsomaki, Barry Make, Ricardo Del Olmo, Alberto Papi, David Price, Laura Benton, Stefan Franzen, Jørgen Vestbo, Hana Mullerova – The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohort
- 759883·Alberto Papi, Rosa Faner, Ian Pavord, Federico Baraldi, Vanessa M McDonald, Mike Thomas, Marc Miravitlles, Nicholas Roche, Alvar Agustí. – From treatable traits to GETomics in airway disease: moving towards clinical practice
- 768799·Surya P Bhatt Richard Casaburi Alvar Agusti et Al. Chronic obstructive pulmonary disease: hiding in plain sight, a Statement from the COPD Foundation Medical and Scientific Advisory Committee
Recuerda que puedes acceder a varios enlaces a artículos dentro de la categoría EPOC en esta web. También puedes acceder otros enlaces en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imagen obtenida en Canva Pro el 18 de mayo de 2023.